glp-1 drugs shortage Taking Stock: What Ro's Supply Tracker Reveals about the Drug Shortages GLP-1 drug shortage resolution boosts

Background Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduce the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus (T2DM)

Is microdosing semaglutide or tirzepatide safe

Unexpected signals included kidney injury and pancreatic cancer

Berberine is not a GLP-1 agonist, though both compounds influence metabolic pathways

Discover Weight Loss GLP-1 Tablets with Orforglipron in India

Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for these drugs.